TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05362513

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Tablets
Description: Group B received a single dose of oral ivermectin 200 mcg per kg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Permethrin Cream
Description: Group A received Permethrin 5% twice with a one-week interval.
Study: NCT05236140

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Perineal electrical stimulation
Description: Perineal electrical stimulation will be performed in lithotomy position via a stimulation device (Enraf Nonius Myomed 632) with perineal surface electrodes. Perineal electrical stimulation will be performed three days a week, 20 minutes a day, a total of 24 sessions for 8 weeks. The stimulation parameters are frequency at 50 Hz, a 5-10s work-rest cycle, and a 300ms pulse width. The symmetric biphasic pulse wave could be delivered over a range of 1-100mA (according to the patient's discomfort level feedback). In this application, three surface electrodes which had 2 cm diameters were used; two electrodes symmetrically at the perianal region (medial to ischial tuberosity); and one electrode at the leg (ground-neutral electrode). Surface electrodes will be used individually for each patient. Perineal electrical stimulation sessions will be performed by an experienced urogynecology rehabilitation nurse.
Study: NCT05284734

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Regional anesthesia intervention
Description: Ultrasound-guided caudal and erector spinae blocks were administered

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Regional anesthesia intervention
Description: Ultrasound-guided caudal and erector spinae blocks were administered
Study: NCT06018506

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR108 injection
Description: Given into the vein (IV; intravenously) on Days 1 and 15 of each treatment cycle
Study: NCT05714475

Intervention type: PROCEDURE
Intervention: Pancreas surgery
Description: Criteria~Inclusion Criteria:~* Isolated pancreatic metastases from Colorectal cancer~* Previous surgery for colorectal cancer~* Surgically manageable lesions: duodenal-pancreatectomy surgical removal of metastatic repetitions in pancreas~pancreaticoduodenectomy total-pancreatectomy distal-pancreatectomy other metastases resection
Study: NCT06432309

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Opicapone 50 mg
Description: Evaluate the addition of the COMT-I, Opicapone, to the Levodopa-Carbidopa intestinal gel in Parkinson's Disease patients with motor fluctuations.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duodopa
Description: Evaluate Levodopa-Carbidopa intestinal gel in Parkinson's Disease patients with motor fluctuations.

Intervention type: DRUG
Group type: OTHER
Intervention: Duodopa
Description: Evaluate Levodopa-Carbidopa intestinal gel in Parkinson's Disease patients with motor fluctuations.
Study: NCT04220086

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pediatric massage therapy
Description: Children with ASD will receive pediatric massage therapy twice a week for 12 consecutive weeks by professional pediatric massage doctor. In addition, they will receive parent provided pediatric massage therapy at home after their parents received the professional pediatric massage therapy training. The frequency of pediatric massage will not be more than once every day and each session last about 30 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Including Applied Behavior Analysis (ABA), Educational intervention, Interpersonal development intervention.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Usual care
Description: Including Applied Behavior Analysis (ABA), Educational intervention, Interpersonal development intervention.

Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: No intervention for healthy controls
Study: NCT06176313

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala Group
Description: The Mandala activity lasts approximately 60 minutes.~• A calm environment is provided during the Mandala activity, and participants are ensured not to be disturbed by external stimuli or individuals unless they request assistance.~Each student's last menstrual date is recorded in an Excel table.~* Two days before the intervention day, students will be contacted and invited to participate in the study.~* Monitoring each student's menstrual cycle, the Mandala activity intervention is scheduled during the late luteal phase of each student's menstrual cycle. The intervention is planned within the 5 days before the expected start of menstrual bleeding on days and hours convenient for the student's class schedule.~* After each session, on the 4th day of the expected menstrual bleeding, students are subjected to PMSÖ.~* On the 4th day of the 4th menstrual period bleeding, the research will be concluded by applying the post-test with PMSÖ to the students.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coping with Premenstrual Symptoms Education Group
Description: The education will be conducted through face-to-face interviews in the master's course classroom at the Faculty of Health Sciences at Bilecik Şeyh Edebali University. The education was conducted using PowerPoint presentations projected onto a white smartboard.~* One month after the completion of the education, a 1st Reminder training will be provided in the master's course classroom within the Faculty of Health Sciences at Bilecik Şeyh Edebali University, using the face-to-face interview method.~* One month after the 1st Reminder training, a 2nd Reminder training will be provided in the master's course classroom within the Faculty of Health Sciences at Bilecik Şeyh Edebali University, using the face-to-face interview method.~* On the 4th day of the 4th menstrual period bleeding, the research will be concluded by applying the post-test with PMSÖ to the students.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: No intervention will be applied to the control group throughout the research. However, students in this group who cope with premenstrual syndrome using medication or non-medication methods will be monitored during the three-month menstrual cycle.~Each student's menstrual cycle in the control group has been recorded in the Excel table. The estimated end of menstruation for each student has been noted.~* At the estimated end of menstruation, the researcher contacts the students in the control group to inquire whether they have used any medication or non-medication methods to cope with premenstrual syndrome.~* Those who use medication or non-medication methods to reduce premenstrual symptoms are excluded from the study.~* On the 4th day of the 4th menstrual period bleeding, the post-test with PMSÖ will be applied to the students.
Study: NCT04662255

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirtobrutinib
Description: Oral

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibrutinib
Description: Oral

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acalabrutinib
Description: Oral

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zanubrutinib
Description: Oral
Study: NCT06147089

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Intervention
Description: Participants in the sleep intervention receive advice on: sleep hygiene/environment, sleep timing, naps, and exposure to light. These advices will be tailored to the personal situation of the participant, as measured during the run-in period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional intervention
Description: Participants in the nutritional intervention receive personalised advice on the distribution of calories and nutrients over 24 hrs, and on specific food products based on the outcomes of the continuous glucose measurements (CGM) during the run-in period. The guidelines will include room for personal dietary preferences.
Study: NCT05995249

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-279
Description: TAK-279 capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-279
Description: TAK-279 capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-279
Description: TAK-279 capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythromycin
Description: Erythromycin tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenytoin
Description: Phenytoin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz
Description: Efavirenz tablets
Study: NCT06347445

Intervention type: OTHER
Intervention: There is no intervention.
Description: There is no intervention.
Study: NCT05952713

Intervention type: DRUG
Intervention: Antidepressant
Description: Treatment with an antidepressant according to Danish register data.

Intervention type: DRUG
Intervention: Antidepressant
Description: Treatment with an antidepressant according to Danish register data.

Intervention type: DRUG
Intervention: Antidepressant
Description: Treatment with an antidepressant according to Danish register data.

Intervention type: DRUG
Intervention: Antidepressant
Description: Treatment with an antidepressant according to Danish register data.

Intervention type: DRUG
Intervention: Antidepressant
Description: Treatment with an antidepressant according to Danish register data.

Intervention type: DRUG
Intervention: Antidepressant
Description: Treatment with an antidepressant according to Danish register data.
Study: NCT05541900

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TEC-Sacredness
Description: The participant is asked to identify and select the correct match on each trial as quickly as possible. Match pairs (i.e., a self-related word paired with a life-related stimulus, a sacredness of life-related stimulus paired with a pleasant stimulus, and a neutral stimulus paired with a neutral stimulus) are first presented to the participant. A grid is then shown containing one of the match pairs along with distraction stimuli.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: TEC-Control
Description: The participant is asked to identify and select the correct match on each trial as quickly as possible. Match pairs (i.e., a neutral stimulus paired with a neutral stimulus) are first presented to the participant. A grid is then shown containing one of the match pairs along with distraction stimuli.
Study: NCT05866549

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Childbirth and Parenting Program
Description: Mindfulness-based childbirth and parenting program will be applied to individuals in this group. The program consists of nine sessions, eight of which will take place during pregnancy. Sessions planned during pregnancy will be held once a week, lasting 8 weeks.
Study: NCT05370508

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
Description: SONALA-001(ALA) given 6-12 hours prior to receiving the MRgFUS

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
Description: SONALA-001(ALA) given 6-12 hours prior to receiving the MRgFUS

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
Description: SONALA-001(ALA) given 6-12 hours prior to receiving the MRgFUS

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
Description: SONALA-001(ALA) given 6-12 hours prior to receiving the MRgFUS

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
Description: SONALA-001(ALA) given 6-12 hours prior to receiving the MRgFUS
Study: NCT06401343

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: Participants randomized to the study group will received Empagliflozin 10mg q.d. for 12 months.
Study: NCT05823467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TMP-SMX DS
Description: Oral Antibiotic - used to treat post operative wound infections.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ciNPT dressing
Description: Negative pressure wound VAC placed on incision post operatively.
Study: NCT04842799

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform
Description: Participants will receive a link to the digital pre-test information. This will consist of text covering: Genetics and cancer risk; Genetics testing; What will happen if your test is positive; What will happen if your test is negative; Implications for insurance.~Where relevant, parts of the text will be linked through to additional information, such as insurance advice from the Association of British Insurers. Participants will be able to call a genetic counsellor on the hotline during weekday office hours, should they have any questions or require further information.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Delivery of Genetic Test Results via the BRCA-DIRECT Platform
Description: Participants will receive a digital message that their results are available. When they click this, they will receive digital notification of their negative (normal) result in short form. Full details will be provided in an individualised letter.
Study: NCT05338541

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tucidinostat and etoposide
Description: Tucidinostat: 3+3 design，14 mg/m2，17.5 mg/m2，23 mg/m2 etoposide: 50mg/m2,
Study: NCT05635955

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Total intravenous anaesthesia will be induced with 0.3mg/kg remimazolam and 0.3mg/kg esketamine, slow injection.~During the painless abortion surgery, if the MOAA/S scores \> 1 or body movements occur, supplemental 0.2 mg/kg remimazolam (IV) will be administrated.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Total intravenous anaesthesia will be induced with 2mg/kg propofol and 0.3mg/kg esketamine, slow injection.~During the painless abortion surgery, if the MOAA/S scores \> 1 or body movements occur, supplemental 0.25 mg/kg propofol (IV) will be administrated.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esketamine
Description: 0.3mg/kg esketamine will be co-administrated in both arms

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: 0.3mg/kg esketamine will be co-administrated in both arms
Study: NCT05367752

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release with TENS conductive glove
Description: Before each MR session, light massage and stretching was applied for five minutes as preparation for the manipulations. The massage included the effleurage technique followed by petrissage and kneading on the cervical and thoracic areas (on the upper three parts of the trapezius muscle, in the suboccipital area, and on the paraspinal cervical muscles). Stretching was applied to the following muscles: upper part of the trapezius, levator scapulae, and the sternocleidomastoid muscle.~Upper trapezius myofascial release, unilateral gross stretch, vertical gross stretch, focused stretch, cranial base myofascial release, gross release of the sternocleidomastoid muscle, and release of the suprahyoid and infrahyoid muscles.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release without TENS conductive glove
Description: Before each MR session, light massage and stretching was applied for five minutes as preparation for the manipulations. The massage included the effleurage technique followed by petrissage and kneading on the cervical and thoracic areas (on the upper three parts of the trapezius muscle, in the suboccipital area, and on the paraspinal cervical muscles). Stretching was applied to the following muscles: upper part of the trapezius, levator scapulae, and the sternocleidomastoid muscle.~Upper trapezius myofascial release, unilateral gross stretch, vertical gross stretch, focused stretch, cranial base myofascial release, gross release of the sternocleidomastoid muscle, and release of the suprahyoid and infrahyoid muscles.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional TENS
Description: Two 40\*50mm silicone electrodes were placed with the negative electrode on the trigger point of the trapezius muscle and the positive one on the acromion. The current frequency was 120Hz and pulse duration 80ms for 30 minutes. This protocol has been proposed by Ebadi et al. (2021)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sham TENS
Description: Two 40\*50mm silicone electrodes were placed with the negative electrode on the trigger point of the trapezius muscle and the positive one on the acromion. The current frequency was 120Hz and pulse duration 80ms for 30 minutes. This protocol has been proposed by Ebadi et al. (2021)
Study: NCT05229341

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diagnostic Procedure
Description: Analysis via DDMS-2

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Review of medical records

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Needle Biopsy
Description: Undergo needle biopsy
Study: NCT04077775

Intervention type: DIAGNOSTIC_TEST
Intervention: assesment
Description: assesment
Study: NCT05394389

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sensory stimulating therapy
Description: therapy session in the snoozlen room accompanied by social support.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sensory stimulating therapy
Description: therapy session in the snoozlen room accompanied by social support.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: social support
Description: ten minutes of conversing.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: social support
Description: ten minutes of conversing.
Study: NCT05736302

Intervention type: OTHER
Intervention: Doubly-Labeled Water
Description: All eligible participants will receive a dose of doubly-labeled water.

Intervention type: OTHER
Intervention: Doubly-Labeled Water
Description: All eligible participants will receive a dose of doubly-labeled water.

Intervention type: OTHER
Intervention: Doubly-Labeled Water
Description: All eligible participants will receive a dose of doubly-labeled water.
Study: NCT05795205

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normal dinner
Description: Participants will consume breakfast at 0830-0855 am, lunch at 1230-1255 pm, followed by dinner at 1800-1825 pm. Snacks will be consumed at 2130-2140 pm.
Study: NCT05425173

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: Chest Physical Therapy as required

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Limb Range of Motion Exercises + Chest Physical Therapy
Description: Limb Range of Motion Exercises + Chest Physical Therapy~Frequency: 4 sessions Time: 5 to 10 minutes
Study: NCT05908305

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: articaine@ (4% 1:100000 epinephrine) dental anesthesia
Description: Administration, calculation and adjustment of dental local anesthesia doses.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: articaine@ (4% 1:100000 epinephrine) dental anesthesia
Description: Administration, calculation and adjustment of dental local anesthesia doses.
Study: NCT06354192

Intervention type: BEHAVIORAL
Intervention: Precision Nudging for Hypertension Management
Description: The hypertension digital health intervention under study combines behavioral science theory with a type of machine learning called reinforcement learning to enable precision nudging: the selection, assembly, and delivery of behavioral science-based messages created to address barriers to, and promote, management of hypertension. The behavioral design process used for the hypertension DHI intentionally includes research on traditionally underserved populations, such as racial and ethnic minorities and people with lower incomes or educational attainment. By including the right ingredients to meet a diverse set of needs and by effectively personalizing the content each individual sees based on their own reactions, the intervention aims to improve health equity by matching each individual to the right behavioral approach.
Study: NCT05514197

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 5000mg
Description: Intravenous loading of 5000mg ascorbic acid with normal saline, totally 100ml Completed before surgical incision

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control Rx
Description: Intravenous loading 100ml normal saline
Study: NCT06210399

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shockwave Therapy
Description: 3 to 6 shock wave treatment sessions will be performed (PiezoWave 2 Control Unit Generator, classification 93/42/EEC class IIb), with a frequency of two sessions per week.
Study: NCT05795205

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Delayed dinner consumption
Description: Participants will consume breakfast at 08:30-08:55 am, lunch at 12:30-12:55 pm, followed by snacks at 18:00-18:10 pm. Dinner will be consumed at 21:30-21:55 pm.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise with delayed dinner consumption
Description: Participants will consume breakfast at 08:30-08:55 am, lunch at 12:30-12:55 pm, followed by snacks at 18:00-18:10 pm. Participants will exercise for 45 min at moderate-intensity 45 min prior to the delayed dinner at 21:30-21:55 pm.
Study: NCT05675514

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release Therapy
Description: The increasing number of basketball players also increases the risk of sports-related injuries. Basketball has the highest injury risk of all sports because the game is so powerful and fast moving. Myofascial release therapy; ıt is a form of manual therapy applied on the muscle fascia complex to restore optimal length, reduce pain and improve functions. It is known to be effective in providing rapid relief of pain and tissue sensitivity. By restoring the length and health of the restricted connective tissue with the myofascial release therapy, it aims to relieve pressure on pain sensitive structures such as nerves and blood vessels, as well as improves sports performance.
Study: NCT05080842

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AC682
Description: Participants will receive AC682 by mouth daily in 28-day cycles.
Study: NCT05955547

Intervention type: OTHER
Intervention: Prognosis Scoring
Description: To determine the prognosis of patients admitted to ICU with a scoring system that includes inflammation and nutritional status

Intervention type: OTHER
Intervention: Prognosis Scoring
Description: To determine the prognosis of patients admitted to ICU with a scoring system that includes inflammation and nutritional status
Study: NCT04904237

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aza-Ven-allo-HSCT
Description: aaa-ven treatment followed by allo-HCTS with reduced toxicity conditioning (RTC) of Fludarabine, Busulifan and Melphalan